United to End Cancer

submitted by: mdanderson

There are those who stand together to make a difference in the fight against cancer — The University of Texas MD Anderson Cancer Center’s community of donors. From across the world and all walks of life, these diverse supporters are united in their generosity toward the Moon Shots Program, the most ambitious assault on cancer ever undertaken by a single institution.

For more information and to make a donation, visit: mdanderson.org/gifts

Personalized treatment for ovarian cancer

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/personalized-treatment-for/id4318482... MD Anderson Cancer Center now has a more strategic approach to treating ovarian cancer which results in a 68% higher rate of removing the whole cancer tumor. Previously, all new ovarian cancer patients would undergo surgery to explore the extent of the disease and remove as much of it as possible. Under this new protocol, all patients undergo this procedure to determine if chemotherapy may...

Prostate Cancer Moon Shot update

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/prostate-cancer-moon-shot/id43184821... . The Prostate Cancer Moon Shot at MD Anderson Cancer Center focuses on: reducing overtreatment; combining therapies used in more advanced cases to treat the disease earlier; and developing new, targeted therapies (including immunotherapy) for patients who see little to no benefit from traditional treatment methods. Timothy Thompson, Ph.D., professor in Genitourinary Medical Oncology, discusses...

Chronic Lymphocytic Leukemia Moon Shot (CLL) update

submitted by: mdanderson

Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia. Michael Keating, M.D., professor in Leukemia at MD Anderson Cancer Center and one of the leaders in the CLL Moon Shot, discusses new advances in treating CLL, including alternatives to chemotherapy and using one’s own immune system to fight this disease.

Immunotherapy: unleashing immune system to attack cancer

submitted by: mdanderson
Cancer immunotherapy treats the immune system rather than the tumor. Jim Allison, Ph.D., professor in Immunology at MD Anderson Cancer Center, has developed an innovative approach that will open doors for treating all types of cancer. Padmanee Sharma, M.D., Ph.D., associate professor in Genitourinary Medical Oncology and Immunology, is lead scientist on immunotherapy clinical trials. Listen to Allison and Sharma discuss their collaboration on MD Anderson’s Moon Shots Program to develop...

Leukemia (AML/MDS) Moon Shots update

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/leukemia-aml-mds-moon-shots/id431848... . Acute Myeloid leukemia (AML) involves an overgrowth of immature blood cells, while myelodysplastic syndromes (MDS) happen when the bone marrow does not produce enough blood cells. MD Anderson Cancer Center is the world’s largest practice for treating AML and MDS. Guillermo Garcia-Manero, M.D., professor in Leukemia at MD Anderson, discusses milestones made with this MD Anderson moon shots,...

Breast and Ovarian Cancers Moon Shot update

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/breast-ovarian-cancers-moon/id431848... The moon shot for breast and ovarian cancer focuses on two diseases: triple-negative breast cancer and high-grade serous ovarian cancer. Jennifer Litton, M.D., associate professor of Breast Medical Oncology, and Shannon Westin, M.D., assistant professor of Gynecologic and Reproductive Medicine, discuss several new and exciting projects underway that can quickly make a difference in the...

Congenital Heart Defects: Could the Developing Heart Hold the Key to New Therapies?

submitted by: mcgheek

Andrew M. Atz, M.D., Chief of the Division of Pediatric Cardiology at MUSC's Children's Hospital, and Kyu-Ho Lee, M.D., PhD, a developmental biologist at MUSC's Cardiovascular Developmental Biology Center, discuss how better understanding the gene signaling involved in the embryonic development of the heart could lead to new adjunctive therapies for congenital heart defects. Learn more about Dr. Lee's work in the November 2013 issue of Progressnotes at MUSChealth.com/progressnotes

Introduction to story boarding

submitted by: kpezzoli

slides with templates

Proton therapy treatment for glioblastoma

submitted by: mdanderson

Glioblastoma multiforme is one of the toughest brain tumors to treat and also is one of the most aggressive. Paul Brown, M.D., professor in Radiation Oncology at MD Anderson Cancer Center, discusses a ground-breaking clinical trial that treats glioblastoma with intensity modulated proton therapy (IMPT). Also in this podcast, Brown explains other new discoveries in adult and childhood brain cancer research and the importance of a skilled proton therapy center.